When ocrelizumab became the first FDA-approved treatment for early forms of multiple sclerosis (MS) in 2017, it offered ...

Multiple sclerosis (MS) is a chronic inflammatory disorder that is thought to impact about 2.3 million people around the ...

Multiple Sclerosis MS is an autoimmune condition that can remain undetected for years A doctor explains how long MS can stay ...

A multiple sclerosis specialist shares insights on quiet progression, and discusses research and treatments for MS activity without relapses.

Illinois engineers fused ultrafast imaging with smart algorithms to peek at living brain chemistry, turning routine MRIs into ...

Multiple Sclerosis, the most common neurological disorder in young adults, with symptoms usually occurring between the ages of 20 and 40 years. The r ...

Multiple sclerosis (MS) can cause a wide range of symptoms. Among the most common are fatigue, muscle weakness, numbness or tingling of the extremities, and bladder problems.

A study of twins reveals two gut bacteria linked to multiple sclerosis, offering new targets for future treatments.

Higher burden of comorbidity linked to worse clinical outcomes in multiple sclerosis. For people with multiple sclerosis (MS), a higher burden of comorbidity is associated with worse clinical ...

The quest to mitigate disability progression in multiple sclerosis (MS) has long been hindered by our limited understanding ...

MULTIPLE SCLEROSIS TREATMENTS; Generic Brand Strength Form Adult Dose; ORAL FORMS: cladribine: Mavenclad: 10mg: tabs: Give 3.5mg/kg cumulative dose divided into 2 yearly treatment courses (1.75mg ...

A blood test might predict when multiple sclerosis patients are about to suffer a relapse in their symptoms, a new study says ...